Sabra Healthcare REIT (SBRA) Expected to Release Earnings on Monday

Sabra Healthcare REIT (NASDAQ:SBRA) is anticipated to announce its Q2 2026 results after the market closes on Monday, August 3rd. Analysts expect the company to post earnings of $0.1711 per share and revenue of $219.3870 million for the quarter. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Investors can check the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Tuesday, August 4, 2026 at 1:00 PM ET.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting the consensus estimate of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The business had revenue of $211.74 million for the quarter, compared to analyst estimates of $209.20 million. During the same period in the previous year, the firm earned $0.37 EPS. The business’s revenue for the quarter was up 20.9% compared to the same quarter last year. On average, analysts expect Sabra Healthcare REIT to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Sabra Healthcare REIT Stock Performance

NASDAQ:SBRA opened at $22.36 on Monday. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. The firm has a 50-day moving average price of $19.68 and a two-hundred day moving average price of $19.84. Sabra Healthcare REIT has a twelve month low of $17.17 and a twelve month high of $22.55. The company has a market capitalization of $5.64 billion, a P/E ratio of 35.49, a price-to-earnings-growth ratio of 1.73 and a beta of 0.65.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 5.4%. The ex-dividend date was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio is 190.48%.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on SBRA shares. Citizens Jmp boosted their price objective on Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a report on Wednesday, July 22nd. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a research report on Wednesday. UBS Group set a $25.00 target price on shares of Sabra Healthcare REIT in a research note on Wednesday. Truist Financial increased their price objective on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd. Finally, Wells Fargo & Company lifted their target price on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Eight equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $22.25.

Institutional Investors Weigh In On Sabra Healthcare REIT

Large investors have recently modified their holdings of the stock. Algert Global LLC acquired a new position in shares of Sabra Healthcare REIT in the 3rd quarter valued at $247,000. Militia Capital Partners LP purchased a new position in shares of Sabra Healthcare REIT in the fourth quarter worth approximately $246,000. Lazard Asset Management LLC raised its holdings in shares of Sabra Healthcare REIT by 60.3% during the third quarter. Lazard Asset Management LLC now owns 11,976 shares of the real estate investment trust’s stock valued at $223,000 after acquiring an additional 4,504 shares during the period. Coldstream Capital Management Inc. purchased a new stake in shares of Sabra Healthcare REIT in the 3rd quarter valued at approximately $213,000. Finally, Tidal Investments LLC acquired a new position in Sabra Healthcare REIT in the 2nd quarter worth approximately $211,000. 99.40% of the stock is owned by institutional investors.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.